Earlier this month, MolDx announced that it would hold (Palmetto + Noridian) two different public meetings on genomic tests for transplant management. Original blog here. Last week, when these were announced, CareDx stock bounced up and down between $12 and $16.
They have now posted meeting materials - specifically, agendas and key questions. There is one set for (kidney & liver) tests and one set for (heart & lung tests.)
Find Kidney/Liver documents here. November 16, 2-4 pm CT.
Find Heart/Lung documents here. November 17, 2-4 pm CT.
I've also put the 4 PDFs in one cloud zip file here.